Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Date
09/28/2016
1800 UTC
GoToMeeting Details
https://global.gotomeeting.com/join/374912925
Dial +1 (872) 240-3212
Access Code: 374-912-925
Audio PIN: Shown after joining the meeting
Meeting ID: 374-912-925
Apologies
Objectives
- Obtain consensus on agenda items
Discussion items
| Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
| 1 | Call to order and role call | JCA |
|
|
| 2 | Approval of 20160627 minutes | JCA |
| |
| 3 | Drug model content | JCA | Decision from Copenhagen 2015, that the prescribing use case is not going to be supported. Thus the need for universal restrictions in the DL is not needed at this time. Questions regarding the names of drug products that contain SOME substances if we disallow the use of universal restrictions: - Which concepts have this potential problem? - How to construct the FSN to make it unambiguous? - If we change the FSN, is it a technical correction or retire and replace?
| |
| 4 | Assessment instrument responses | JCA | Policy on addition of assessment tool responses to the International edition. IHTSDO currently accepts "names" of assessment instruments and staging scales; however, there is nothing in the editorial guide that specifically addresses the responses to assessment instrument questions. As many of these are extremely context dependent, being tied specifically to the particular instrument, what should be the policy of IHTSDO to requests to add assessment instrument responses to the International release. Example: Requests to add responses to Tinetti balance assessment tool
| |
| 5 | EAG self evaluation | JCA | The EAG has been asked to do a self evaluation after the first two years of operarion. We need to answer the following questions given that the role of the EAG is advisory.
| |
| 6 | Goals for next year | EAG | Develop a set of 1-2 primary goals for the EAG for next year. What are the most important topics the group should attempt to address in the coming year? | |
| 7 | Requirement for matching description to FSN | JCA | A final proposal to resolve issues around the requirement for matching descriptions for FSN: 1. SCA will automatically create a matching description to the FSN. 2. Editors will determine whether the matching FSN provides a useful clinical description 3. Useful descriptions will be maintained in the terminology. 4. Those descriptions determined to be not useful will be removed. 5. SCA will present a warning for those concepts where the matching description has been removed, but will not prevent saving the concept. |
|
| 8 | Disjunctive components Final agreement | JCA | Review of disjunctive representations:
Impact of this is that a number of LOINC terms become ineligible for addition to SNOMED CT. |
|
| 7 | Action item review | EAG | ||
| 8 | Potential agenda topics for Wellington meeting | JCA | We are meeting for a full day in New Zealand. Need substantive topics to move forward. | |
| 9 | Additional items | EAG |
Meeting Files
| View file | ||||
|---|---|---|---|---|
|
Meeting minutes